INFINITUM ASSET MANAGEMENT LLC 13D and 13G filings for ArriVent BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:34 pm Purchase | 2025-12-31 | 13G | ARRIVENT BIOPHARMA INC AVBP | INFINITUM ASSET MANAGEMENT LLC | 4,123,923 9.900% | 705,000 (+20.62%) | Filing |
| 2025-08-13 6:00 pm Purchase | 2025-05-01 | 13G | ARRIVENT BIOPHARMA INC AVBP | INFINITUM ASSET MANAGEMENT LLC | 3,418,923 9.900% | 1,352,685 (+65.47%) | Filing |
| 2025-05-15 4:36 pm Purchase | 2025-05-01 | 13G | ARRIVENT BIOPHARMA INC AVBP | INFINITUM ASSET MANAGEMENT LLC | 2,066,238 6.100% | 2,066,238 (New Position) | Filing |